SODIUM IODIDE I-123 ORAL SOLUTION

Google image searchProduct monograph

Active ingredient

sodium iodide 123 i, 74 MBq/0.08 ML

DIN: 02478366

Dosage form(s): SOLUTION

Route(s) of administration: ORAL

Schedule: Schedule C

Company: BWXT MEDICAL LTD.

Date: 17-DEC-2019

ATC:

• V09 — DIAGNOSTIC RADIOPHARMACEUTICALS (ATC, ATC/DDD, )
• V09F — THYROID (ATC, ATC/DDD)
• V09FX — Various thyroid diagnostic radiopharmaceuticals (ATC, ATC/DDD)
• V09FX02 — SODIUNM IODIDE 123 I (ATC/DDD)

External Links for Sodium Iodide I-123 Oral Solution

Search on Google

• Sodium Iodide I-123 Oral Solution side effects
• Sodium Iodide I-123 Oral Solution dosage
• sodium iodide 123 i side effects
• sodium iodide 123 i dosage